FDA Expands Approval of Drug to Stave Off Type 1 Diabetes
The FDA expanded the approval for teplizumab (Tzield), a biologic that delays the progression of preclinical type 1 diabetes to the symptomatic form, to include treatment in kids as young…
The FDA expanded the approval for teplizumab (Tzield), a biologic that delays the progression of preclinical type 1 diabetes to the symptomatic form, to include treatment in kids as young…
Scientists have cured type 1 diabetes in mice, without long-term immune suppression. In type 1 diabetes, the immune system attacks insulin-producing cells, and replacing them with transplanted cells from donors…
Your early life may quietly set the stage for developing Type 1 diabetes, an increasingly common, lifelong condition that can significantly affect daily life. Our team’s research, published in the…
Researchers at UW Medicine in Seattle seek adults recently diagnosed with type 1 diabetes for a clinical trial of an investigational drug that may protect insulin-producing cells from destruction. Type…
Case Presentation A 2.5-year-old girl presents to her primary care physician with increased thirst, lethargy, irritability, excessive urination, vision difficulties, and fruity breath. One week prior, the patient—who is recently…
Even when fitness looks normal, hidden changes in oxygen use and microvascular function may already be emerging in adolescents with type 1 diabetes. Study: Cardiovascular and autonomic nervous system response…
Breakthrough T1DTzield approved for children ages one and older in stage 2 T1DThe U.S. Food and Drug Administration (FDA) approved Tzield (teplizumab-mzwv) for use in children in stage 2 type…
NEWYou can now listen to Fox News articles! Researchers have developed an mRNA therapy that could help prevent or slow the development of type 1 diabetes. With this chronic autoimmune…
CureusEuglycemic Diabetic Ketoacidosis-Like State During the Treatment of Diabetic Ketoacidosis in Fulminant Type 1 Diabetes: A Case ReportDiabetic ketoacidosis (DKA) is a life-threatening acute metabolic complication of diabetes characterized by…
A single jab hailed as a ‘potential cure’ for type 1 diabetes will be trialled this year – raising hopes it could finally end the need for multiple daily insulin…